Clinical and microbiological evaluation of Bach's Floral and Ozone Therapy in treating chronic periodontitis in Type 2 Diabetic patients

niversidade Federal Fluminense – Instituto de Saúde de Nova Friburgo0 个研究点开始时间: 2021年5月5日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Criteria for selecting the subjects were as follows: the presence of type 2 diabetes and chronic periodontitis. Diabetes mellitus established according to the American Diabetes Academy, with Hba1c higher than or equal to 6.5%, fasting blood glucose> 126 mg/dl. Patients diagnosed with diabetes and treatment with an endocrinologist using metformin, with Hba1c and fasting blood glucose within the normal range were also accepted, that is, Hba1c <6.5 and fasting blood glucose 100 mg/dl. Chronic periodontitis, established according to new criterion, probing depth (PD) with 3 mm on two or more teeth.

•The subjects were excluded when: they showed hypersensitivity to the floral components and any evidence of systemic factors that modify periodontal disease, except for diabetes mellitus; they may directly interfere in completing the work (bias). The factors described in the literature include osteoporosis types I and II, alcoholism, acquired or induced immunosuppression, any change described in the novel as a potential modifier of the periodontal disease profile, and physical/emotional stress drugs that influence periodontal tissues. Samples from pregnant or lactating women, individuals who have taken antibiotics in the past six months, clinical manifestations of oral candidiasis, anti-inflammatories or hormone replacement therapy, and who have received periodontal treatment in the last six months before the procedure will be excluded.

发起方

niversidade Federal Fluminense – Instituto de Saúde de Nova Friburgo